首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   251234篇
  免费   12881篇
  国内免费   434篇
耳鼻咽喉   3363篇
儿科学   7785篇
妇产科学   5108篇
基础医学   36113篇
口腔科学   5680篇
临床医学   20310篇
内科学   55037篇
皮肤病学   7006篇
神经病学   22503篇
特种医学   7754篇
外国民族医学   105篇
外科学   31873篇
综合类   1249篇
一般理论   68篇
预防医学   22608篇
眼科学   4931篇
药学   17575篇
中国医学   723篇
肿瘤学   14758篇
  2023年   1295篇
  2022年   962篇
  2021年   3678篇
  2020年   2212篇
  2019年   4088篇
  2018年   7740篇
  2017年   5108篇
  2016年   5180篇
  2015年   5737篇
  2014年   6095篇
  2013年   9800篇
  2012年   16829篇
  2011年   16843篇
  2010年   8459篇
  2009年   6404篇
  2008年   14407篇
  2007年   15470篇
  2006年   14327篇
  2005年   14119篇
  2004年   13267篇
  2003年   12165篇
  2002年   11537篇
  2001年   6774篇
  2000年   6829篇
  1999年   6121篇
  1998年   1089篇
  1997年   906篇
  1996年   829篇
  1992年   3504篇
  1991年   3216篇
  1990年   3029篇
  1989年   2779篇
  1988年   2624篇
  1987年   2450篇
  1986年   2332篇
  1985年   2140篇
  1984年   1588篇
  1983年   1380篇
  1982年   787篇
  1979年   1402篇
  1978年   979篇
  1977年   924篇
  1975年   954篇
  1974年   1125篇
  1973年   1132篇
  1972年   1083篇
  1971年   1047篇
  1970年   963篇
  1969年   1011篇
  1968年   895篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
82.
83.
84.
85.
86.
87.

Introduction

The fast track / ultra-fast-track protocols are techniques used to optimise the patient care process and a quick recovery after cardiac surgery. They are one of the mainstays of efficient practice. With their use, the length of hospital and intensive care unit (ICU) stays are reduced, with a direct impact on costs and the quality of the health service.

Objective

To compare the length of stay in the ICU, length of hospital stay, and post-operative mortality in ultra-fast-track extubated (uFTE) patients and those with conventional extubation (CE) after cardiac surgery.

Methods

Longitudinal, analytical, retrospective study was conducted, with the period between the time of surgery and discharge being included as the study period.

Results

A total of 396 patients older than 18 years who required cardiac surgery were included, of whom 207 patients had (uFTE) and 189 had CE. Although the groups were not comparable due to the statistical differences found, when performing the multivariate adjustment, uFTE maintained its statistical independence and was associated with lower cardiovascular morbidity, such as myocardial ischaemia (95% CI: 0.37-0.86; P = .01) and lower post-surgical vasopressor requirement (95% CI: 0.18-0.49; P < .01). No significant differences were found in the length of hospital stay, ICU stay, or post-operative mortality in the ICU.

Conclusion

Implementing the uFTE strategy, decreases cardiovascular morbidity and vasopressor requirement. The change to uFTE should be accompanied by changes in models and practices in patient recovery to standardised protocols. This study shows that uFTE did not reduce the length of ICU stay, hospital stay, or mortality.  相似文献   
88.
89.
90.
Introduction: The rising prevalence of musculoskeletal pathologies in developed countries has caused a dramatic impact on social welfare. Amidst these musculoskeletal pathologies is Rheumatoid arthritis (RA), a chronic systemic autoimmune disease that mostly affects the synovium. RA metabolic-associated alterations, including distorted adipokine production, enhance RA inflammatory environment. Among the altered adipokines, visfatin is particularly involved in RA inflammation and catabolism and stands out as an essential enzyme linked to critical cell features.

Areas covered: We discuss the potential mechanism supporting the contribution of visfatin to RA and the association between RA and obesity. We discuss the repurposing of cancer-tested drugs to inhibit visfatin in the context of RA. Additionally, we address the possibility of combining these drugs with current RA therapy. Finally, we explore the future of visfatin as an RA biomarker or therapeutic target.

Expert opinion: Inhibition of visfatin has become an interesting therapeutic approach for RA pathology. Such a feat has already been attained in oncology using small molecule inhibitors, which suggest that a similar course of action would be worth pursuing in the RA context. Visfatin will become an important biomarker and therapeutic target for RA.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号